Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 28, 2020 - Issue 1
Submit an article Journal homepage
369
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Ocular Features in Chinese Patients with Blau Syndrome

Shijing WuDepartment of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, ChinaView further author information
,
Linqing ZhongDepartment of Pediatrics, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, ChinaView further author information
,
Zixi SunDepartment of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, ChinaView further author information
,
Tian ZhuDepartment of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, ChinaView further author information
,
Hongmei SongDepartment of Pediatrics, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, ChinaView further author information
&
Ruifang SuiDepartment of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, ChinaCorrespondence[email protected]
View further author information
Pages 79-85 | Received 08 Jul 2018, Accepted 02 Jan 2019, Published online: 26 Feb 2019

REFERENCES

  • Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985;107:689–693.
  • Jabs DA, Houk JL, Bias WB, Arnett FC. Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med. 1985;78:801–804.
  • Tromp G, Kuivaniemi H, Raphael S, et al. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am J Hum Genet. 1996;59:1097–1107.
  • Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29:19–20. doi:10.1038/ng720.
  • Kanazawa N, Okafuji I, Kambe N, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood. 2005;105:1195–1197. doi:10.1182/blood-2004-07-2972.
  • Rose CD, Martin TM, Wouters CH. Blau syndrome revisited. Curr Opin Rheumatol. 2011;23:411–418. doi:10.1097/BOR.0b013e328349c430.
  • Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F. NOD2-associated diseases: bridging innate immunity and autoinflammation. Clin Immunol. 2010;134:251–261. doi:10.1016/j.clim.2009.05.005.
  • Sarens IL, Casteels I, Anton J, et al. Blau syndrome-associated uveitis: preliminary results from an international prospective interventional case series. Am J Ophthalmol. 2018;187:158–166. doi:10.1016/j.ajo.2017.08.017.
  • Wang W, Wei M, Song H, Qiu Z. [Mutations of NOD2 gene and clinical features in Chinese Blau syndrome patients]. Zhonghua Er Ke Za Zhi. 2014;52:896–901.
  • Caso F, Costa L, Rigante D, et al. Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis. Autoimmun Rev. 2014;13:1220–1229. doi:10.1016/j.autrev.2014.08.010.
  • Okafuji I, Nishikomori R, Kanazawa N, et al. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheumatol. 2009;60:242–250. doi:10.1002/art.24134.
  • Saulsbury FT, Wouters CH, Martin TM, et al. Incomplete penetrance of the NOD2 E383K substitution among members of a pediatric granulomatous arthritis pedigree. Arthritis Rheum. 2009;60:1804–1806. doi:10.1002/art.24532.
  • Harada J, Nakajima T, Kanazawa N. A case of blau syndrome with NOD2 E383K mutation. Pediatr Dermatol. 2016;33:e385–e387. doi:10.1111/pde.12908.
  • Rose CD. Blau syndrome: a systemic granulomatous disease of cutaneous onset and phenotypic complexity. Pediatr Dermatol. 2017;34:216–218. doi:10.1111/pde.13021.
  • Ebrahimiadib N, Samra KA, Domina AM, et al. A novel NOD2-associated mutation and variant blau syndrome: phenotype and molecular analysis. Ocular Immunology Inflammation. 2018;26:57–64. doi:10.1080/09273948.2016.1185529..
  • Milman N, Ursin K, Rodevand E, Nielsen FC, Hansen TVO. A novel mutation in the NOD2 gene associated with Blau syndrome: a Norwegian family with four affected members. Scand J Rheumatol. 2009;38:190–197. doi:10.1080/03009740802464194.
  • Osborne GE, Mallon E, Mayou SC. Juvenile sarcoidosis after BCG vaccination. J Am Acad Dermatol. 2003;48:S99–102. doi:10.1067/mjd.2003.158.
  • Kim TH, Payne U, Zhang X, et al. Altered host: pathogeninteractions conferred by the Blau syndrome mutation of NOD2. Rheumatol Int. 2007;27:257–262. doi:10.1007/s00296-006-0250-0.
  • Inohara N, Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol. 2003;3:371–382. doi:10.1038/nri1086.
  • Glass DA 2nd, Maender J, Metry D. Two pediatric cases of Blau syndrome. Dermatol Online J. 2009;15:5.
  • Arvesen KB, Herlin T, Larsen DA, et al. Diagnosis and treatment of blau syndrome/early-onset sarcoidosis, an autoinflammatory granulomatous disease, in an infant. Acta Derm Venereol. 2017;97:126–127. doi:10.2340/00015555-2485.
  • Simonini G, Xu Z, Caputo R, et al. Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis Rheumatol. 2013;65:513–518. doi:10.1002/art.37776.
  • Martin TM, Zhang Z, Kurz P, et al. The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity. Arthritis Rheumatol. 2009;60:611–618. doi:10.1002/art.24222.
  • Lu L, Shen M, Jiang D, et al. Blau syndrome with good Reponses to Tocilizumab: A case report and focused literature review. Semin Arthritis Rheum. 2018;47:727–731. doi:10.1016/j.semarthrit.2017.09.010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.